NLRP3 and Alzheimer disease: Finally, the importance of the NLRP3 inflammasome pathway in neuroinflammation and neurodegenerative diseases, such as AD, has been established [125], and very recent data on its modulation via allicin have been reported, whereas no evidence has been shown for AGE, implying the need for further characterization.